X-linked CD40 ligand deficiency in a 1-year-old male Shih Tzu with secondary Pneumocystis pneumonia.
Kristen MerrillEmily L CoffeyEva FurrowIsabelle MasseauHansjörg RindtCarol N ReineroPublished in: Journal of veterinary internal medicine (2020)
An approximately 1-year-old male intact Shih Tzu dog was referred to a tertiary facility with a history of progressive tachypnea, increased respiratory effort, and weight loss over a 3-month period that failed to improve with empirical antimicrobial treatment. Upon completion of a comprehensive respiratory evaluation, the dog was diagnosed with severe Pneumocystis pneumonia and secondary pulmonary hypertension. Clinical signs resolved and disease resolution was confirmed after completion of an 8-week course of trimethoprim-sulfonamide, 4-week tapering dose of prednisone to decrease an inflammatory response secondary to acute die-off of organisms, a 2-week course of clopidogrel to prevent clot formation, and a 2-week course of a phosphodiesterase-5 inhibitor to treat pulmonary hypertension. Immunodiagnostic testing and genetic sequencing were performed to evaluate for potential immunodeficiency as an underlying cause for the development Pneumocystis pneumonia, and identified an X-linked CD40 ligand deficiency.
Keyphrases
- pulmonary hypertension
- respiratory failure
- inflammatory response
- weight loss
- pulmonary artery
- placebo controlled
- liver failure
- acute coronary syndrome
- pulmonary arterial hypertension
- replacement therapy
- bariatric surgery
- community acquired pneumonia
- percutaneous coronary intervention
- randomized controlled trial
- single cell
- nk cells
- hepatitis b virus
- roux en y gastric bypass
- lps induced
- copy number
- coronary artery disease
- atrial fibrillation
- adipose tissue
- extracorporeal membrane oxygenation
- risk assessment
- body mass index
- toll like receptor
- single molecule
- climate change
- smoking cessation
- study protocol